Yamasaki T et al. |
Effect of a new immunosuppressive agent, FTY720, on survival of islet allografts. |
|
Cell Transplant |
pmid:9710310
|
Li XK et al. |
Induction of lymphocyte apoptosis by a novel immunosuppressant FTY720: relation with Fas, Bcl-2 and Bax expression. |
|
Transplant. Proc. |
pmid:9123299
|
Katsel P et al. |
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease? |
|
Neurochem. Res. |
pmid:17342407
|
Law SL et al. |
Gene transfer mediated by sphingosine/ dioleoylphosphatidylethanolamine liposomes in the presence of poloxamer 188. |
|
Drug Deliv |
pmid:16401595
|
|
|
|
|
pmid:
|
Sordillo PP et al. |
Review: The Prolonged QT Interval: Role of Pro-inflammatory Cytokines, Reactive Oxygen Species and the Ceramide and Sphingosine-1 Phosphate Pathways. |
|
In Vivo |
pmid:26546519
|
Galvão VR et al. |
Prolonged administration of FTY720 does not cause renal toxicity in mice. |
|
Transplant. Proc. |
pmid:15808564
|
Schmid G et al. |
FTY720 inhibits tumor growth and angiogenesis. |
|
Transplant. Proc. |
pmid:15808563
|
Kataoka H et al. |
Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice. |
|
Transplant. Proc. |
pmid:15808562
|
DeAngelis T and Lublin F |
Neurotherapeutics in multiple sclerosis: novel agents and emerging treatment strategies. |
|
Mt. Sinai J. Med. |
pmid:18500719
|